Boston Scientific, At Investor Day Wed., Will Highlight Plans To Launch ~75 New Products By 2022, Sees Moderate-, High-Growth Markets Reaching ~80% Of Sales By 2022, Sees Compound Annual Growth Rate Through 2022 6-9%
Benzinga Newsdesk